Showing results (181-190 of 302) with videos related to
Sort By:
Pageof 31
Transplantation|January 3, 2020
Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant CohortGabriela Gautier Vargas, Jérome Olagne, Anne Parissiadis, et al.Non-Coding RNA Research|June 9, 2025
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemiaEmma Brisot, Pierre-Marie Leprêtre, Eya Hamza, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN studyAurélie Lenglet, Sophie Liabeuf, Najeh El Esper, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2006
Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipientsFlavio Vincenti, Amado de Andrés, Thomas Becker, et al.Nephrologie & Therapeutique|March 11, 2025
Early conversion to belatacept post-transplantation: state of the art and expert opinionJohan Noble, Dany Anglicheau, Gilles Blancho, et al.Seminars in Dialysis|June 7, 2005
How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?Irina Shahapuni, Janet Mansour, Laïd Harbouche, et al.Journal of Hypertension|November 21, 2009
Pulse wave velocity and vascular calcification at different stages of chronic kidney diseaseMohamed Temmar, Sophie Liabeuf, Cédric Renard, et al.Transplantation|August 23, 2016
Recent Changes in Chronic Kidney Disease-Mineral and Bone Disorders and Associated Fractures After Kidney TransplantationPeggy Perrin, Clotilde Kiener, Rose-Marie Javier, et al.Journal of the American College of Cardiology|January 22, 2011
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrelOlivier Morel, Soraya El Ghannudi, Laurence Jesel, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2023
Chronic kidney disease is a key risk factor for aortic stenosis progressionAlexandre Candellier, Yohann Bohbot, Agnes Pasquet, et al.Pageof 31